|
Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation
&
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
CDER News
June 12, 2009
June 11, 2009
June 10, 2009
June 9, 2009
June 8, 2009
Drug
Approvals:
June 12, 2009
-
-
Besivance
(besifloxacin
hydrochloride)
Ophthalmic
Suspension,
Bausch &
Lomb, Inc.,
Approval
-
Glyburide
and
Metformin
Hydrochloride
Tablets,
Indicus
Pharma, LLC,
Approval
-
Lupron
Depot-3
(leuprolide
acetate)
Injection,
Abbott
Laboratories,
Labeling
Revision
-
PEG 3350 and
Electrolytes
Oral
Solution,
Novel
Laboratories,
Inc.,
Approval
-
Ropinirole
Hydrochloride
Tablets,
Zydus
Pharmaceuticals
USA, Inc.,
Approval
-
Sanctura
(trospium
chloride)
Tablets,
Allergan,
Inc.,
Labeling
Revision
-
Sanctura XR
(trospium
chloride)
Extended-Release
Capsules,
Allergan,
Inc.,
Labeling
Revision
Meetings & Conferences:
-
Applied
Biopharmaceutics
and Quality by
Design for
Dissolution/Release
Specification
Setting: Product
Quality for
Patient Benefit,
June 10-12,
2009, Hilton
Washington
DC/Rockville
1750 Rockville
Pike, Rockville,
MD.
Meeting
Information
-
2009 PDA/FDA
Asia-Pacific
Pharmaceutical
Ingredient
Supply Chain
Conference, June
15-19, 2009,
Shanghai, China.
Meeting
Information and
registration
-
2009 PDA/FDA
Joint Regulatory
Conference,
September 14-18,
2009,
Renaissance
Hotel, 999 9th
Street NW,
Washington, D.C.
Meeting
Information and
registration
-
Quality Risk
Management
Implementation
Strategies; US
FDA/CDER and
University of
Rhode Island
College of
Pharmacy
Conference,
June 15-16,
2009, Hyatt
Regency
Bethesda,
Bethesda,
Maryland.
Meeting
Information.
CDER
Drug Links
|
Hot Topics
H1N1 Virus (Flu)
Information
GARDASIL (Human Papillomavirus
Vaccine)
Zostavax (Herpes Zoster Vaccine)
Advisory Committees
Blood
Establishment Registration
FDA's
Office of Criminal Investigations (OCI)
Forms
Guidances/Guidelines/Points to
Consider
Impact
of Severe Weather Conditions on
Biological Products
Proposed and Final Rules
Human
Cell and Tissue Establishment
Registration
Recall
& Product Withdrawals
Reporting Adverse Events and Product
Deviations
Safety
Information
Shortages
What's
New
CBER Links
|
June 15, 2009
June 12, 2009
June 11, 2009
June 9, 2009
June 8, 2009
|
|
This
Week
Rule Changes:
21 CFR Parts
558
-
520 |
|
Friday,
June
12, 2009 |
RULES
New Animal Drugs for Use in
Animal Feeds:
Chlortetracycline
2791927920 [E913849]
[TEXT] [PDF]
NOTICES
Debarment Orders:
Allyn M.
Norman
28050 [E913766]
[TEXT] [PDF]
Mary E.
Sawaya a.k.a. Marty Sawaya
28049 [E913929]
[TEXT] [PDF]
|
|
Thursday,
June 11, 2009 |
RULES
Oral Dosage Form New Animal
Drugs:
Methimazole
2770627707 [E913685]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
27802 [E913716]
[TEXT] [PDF]
Draft Guidance for Industry:
Questions and Answers
Regarding the Reportable
Food Registry, etc.
2780327804 [E913614]
[TEXT] [PDF]
Meetings:
Peripheral and Central
Nervous System Drugs
Advisory Committee
2780927810 [E913767]
[TEXT] [PDF]
|
|
Wednesday,
June 10, 2009 |
NONE
|
|
Tuesday,
June 09, 2009 |
NOTICES
International Conference on
Harmonisation; Guidance on
Q8(R1) Pharmaceutical
Development:
Addition of Annex;
Availability
2732527326 [E913374]
[TEXT] [PDF]
Meetings:
Cardiovascular and Renal
Drugs Advisory Committee
27329 [E913375]
[TEXT] [PDF]
Hematology and Pathology
Devices Panel of the Medical
Devices Advisory Committee
2732827329 [E913373]
[TEXT] [PDF]
Interagency Retail Listeria
monocytogenes Risk
Assessment
2727627278 [E913378]
[TEXT] [PDF]
Issues in Clinical Trials of
Antimycobacterial Drugs for
Tuberculosis; Public
Workshop
27335 [E913419]
[TEXT] [PDF]
Oncologic Drugs Advisory
Committee
2732727328 [E913372]
[TEXT] [PDF]
Psychopharmacologic Drugs
Advisory Committee
2732627327 [E913371]
[TEXT] [PDF]
|
|
Monday,
June 08, 2009 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
2714527146 [E913276]
[TEXT] [PDF]
Draft and Revised Draft
Guidances for Industry
Describing Product-Specific
Bioequivalence
Recommendations;
Availability
2714627148 [E913272]
[TEXT] [PDF]
Final Guidances for Industry
Describing Product-Specific
Bioequivalence
Recommendations;
Availability
2714827150 [E913261]
[TEXT] [PDF]
Guidance for Industry on
Medication Guides:
Adding a Toll-Free Number
for Reporting Adverse
Events; Availability
2715227153 [E913273]
[TEXT] [PDF]
Meetings:
Cardiovascular and Renal Drugs Advisory Committee
2715527156 [E913315]
[TEXT] [PDF]
|
|
|